Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BALCHEM CORP Director's Dealing 2025

Apr 12, 2025

31041_dirs_2025-04-11_4ae908dc-c691-4006-a2ac-c54de0db086c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2025-02-12

Reporting Person: Reid Martin Luther (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-12 Common Stock A 1000 Acquired 6761 Direct
2025-02-13 Common Stock A 2889 Acquired 9650 Direct
2025-02-13 Common Stock F 1059 $163.14 Disposed 8591 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-12 Stock Option $159.18 A 3300 Acquired 2035-02-12 Common Stock (3300) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 561 Indirect

Footnotes

F1: Ownership of restricted stock vests in Reporting Person ratably over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

F2: Represents the vesting of performance stock units (includes 47 dividend equivalent shares) for the 2022-2024 performance period.

F3: 1,059 of the 2,889 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.

F4: Options vest 20% Year 1; 40% Year 2; and 40% Year 3.